Trichotillomania, stereotypic movement disorder, and related disorders.
Dan J Stein, Joseph P Garner, Nancy J Keuthen...
https://pubmed.ncbi.nlm.nih.gov/17880861/Actively Recruiting
Led by Oslo University Hospital · Updated on 2024-03-05
150
Participants Needed
1
Research Sites
143 weeks
Total Duration
Researchers are evaluating the effectiveness of group-based cognitive behavioral therapy CBT for trichotillomania, a hair pulling disorder, in adolescents and adults aged 16 to 67. This multicenter study is conducted at three clinical sites in Norway and aims to assess outcomes using established clinical scales. The study focuses on ACT-enhanced habit reversal training, combining acceptance and commitment therapy with habit reversal techniques. Participants receive manualized group therapy consisting of ten weekly sessions lasting three hours each. The therapy is structured with the first three sessions focused on habit reversal training, the next three on acceptance and commitment therapy, and the final four sessions integrating both approaches. Additionally, participants attend two or three booster sessions within the first year after completing treatment to support long-term benefits. Throughout the study, participants complete assessments at baseline, after 12 weeks of treatment, and at one-year follow-up. These include self-report and clinical interview scales measuring hair pulling severity and global clinical impressions. Researchers also evaluate changes in depression, anxiety, metacognition, and acceptance related to trichotillomania. Data analysis uses longitudinal methods to understand treatment effects over time.
CONDITIONS
Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder)
B
Benjamin Hummelen, Ph.D., M.D.
E
Erna M Moen, Master
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Oslo University Hospital
Lead Sponsor
Sorlandet Hospital HF
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 10 to 12 weeks
Participants attend ten weekly group therapy sessions focusing on habit reversal training, acceptance and commitment therapy, and their integration. They also receive two or three booster sessions within the first year after treatment.
Weekly sessions plus booster sessions during the first year
Duration - 12 months after treatment
Participants complete assessments at baseline, after treatment, and at one-year follow-up to measure changes in symptoms and overall clinical improvement.
3 assessment visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Dan J Stein, Joseph P Garner, Nancy J Keuthen...
https://pubmed.ncbi.nlm.nih.gov/17880861/Dan J Stein, Jon E Grant, Martin E Franklin...
https://pubmed.ncbi.nlm.nih.gov/20533371/Douglas W Woods, Chad T Wetterneck, Christopher A Flessner
https://pubmed.ncbi.nlm.nih.gov/16039603/David C Houghton, Matthew R Capriotti, Alessandro S De Nadai...
https://pubmed.ncbi.nlm.nih.gov/26422605/Nancy J Keuthen, Barbara O Rothbaum, Jeanne Fama...
https://pubmed.ncbi.nlm.nih.gov/26165460/Oslo University Hospital
Lead Sponsor
Sorlandet Hospital HF
Collaborating Sponsor